Chinese firm obtains approval to begin human testing for potential coronavirus vaccine

China has given on Monday its greenlight for a coronavirus vaccine candidate co-developed by Anhui Zhifei Longcom Biopharmaceutical and the Institute of Microbiology of the Chinese Academy of Sciences, Reuters reported.
Anhui Zhifei is a business unit of Chinese publicly listed Chongqing Zhifei Biological Products.
The approval will enable the firm to begin clinical trials.
To date, Chinese researchers and companies are testing six experimental shots in humans, and more than a dozen potential vaccines are in different stages of clinical trials globally, according to Reuters.